then we find under section #4 the following: "The Company has concurrently entered into an agreement with a US - ISRAELI marketing consulting Co called, Strategic Marketing Technologies Corp, whereby they will assist Safecode Drug Technologies Corp to conceptualize and manufacture a prototype of its patent pending medical product for a demonstration and the possible market penetration into the US Department of Defense. The project is estimated to be completed over a period of 6-9 months and will cost $53,000 payable in milestones over the related period".
So it seems that while there may be a period of this stock marking time in a very low cost per share, it seems that good things will eventually come to those that wait. (IMO)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.